Biochemical markers of thyroid hormone action (eg CPK, cholesterol), lack diagnostic sensitivity but may have a role in monitoring treated cases and may support a diagnosis of CCH (Ferretti et al. 1999). The gene discussed is PIK3C2A; the disease is columnar cell hyperplasia of the breast.